Jerome A. Zack

Active 1988–2025

81
Papers
17,908
Citations
71
h-index
80
i10-index

Citations

Citations per year for Jerome A. Zack1988: 2 citations1989: 7 citations1990: 26 citations1991: 45 citations1992: 80 citations1993: 92 citations1994: 85 citations1995: 97 citations1996: 92 citations1997: 97 citations1998: 146 citations1999: 116 citations2000: 149 citations2001: 128 citations2002: 176 citations2003: 170 citations2004: 193 citations2005: 168 citations2006: 166 citations2007: 178 citations2008: 174 citations2009: 153 citations2010: 161 citations2011: 180 citations2012: 156 citations2013: 131 citations2014: 142 citations2015: 109 citations2016: 108 citations2017: 131 citations2018: 101 citations2019: 396 citations2020: 416 citations2021: 357 citations2022: 261 citations2023: 146 citations2024: 245 citations2025: 121 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,916 citing papers, 45.1% of this breakdownChina: 385 citing papers, 6% of this breakdownUnited Kingdom: 349 citing papers, 5.4% of this breakdownFrance: 287 citing papers, 4.4% of this breakdownGermany: 275 citing papers, 4.3% of this breakdownCanada: 249 citing papers, 3.8% of this breakdownItaly: 202 citing papers, 3.1% of this breakdownAustralia: 183 citing papers, 2.8% of this breakdownNetherlands: 157 citing papers, 2.4% of this breakdownJapan: 154 citing papers, 2.4% of this breakdownSwitzerland: 128 citing papers, 2% of this breakdownSpain: 115 citing papers, 1.8% of this breakdown
0%45.1%Other 16.5%

Fields

  • Immunology and Microbiology49.1%
  • Medicine22.8%
  • Biochemistry, Genetics and Molecular Biology19.9%
  • Neuroscience4.8%
  • Psychology0.8%
  • Agricultural and Biological Sciences0.6%
  • Other2%

Topics

  • HIV Research and Treatment13.4%
  • Immune Cell Function and Interaction8.3%
  • HIV/AIDS drug development and treatment4.9%
  • HIV/AIDS Research and Interventions4%
  • T-cell and B-cell Immunology4%
  • CRISPR and Genetic Engineering2.5%
  • Other62.9%

Coauthors

All papers

Open in search
  1. Interferon-Inducible Cholesterol-25-Hydroxylase Broadly Inhibits Viral Entry by Production of 25-Hydroxycholesterol

    Authors: , , , , , , , , , , , , , - Immunity 2012 cited by 684

  2. Changes in thymic function with age and during the treatment of HIV infection

    Authors: , , , , , , , , , , , , , - Nature 1998 cited by 1,904

  3. Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Siwen Hu‐Lieskovan, Paula Kaplan‐Lefko, Satiro De Oliveira, Christopher S. Seet, Sarah Larson, Stephen J. Forman, James R. Heath, Jerome A. Zack, Gay M. Crooks, Caius G. Radu, Antoni Ribas, Donald B. Kohn, Owen N. Witte, Lili Yang - Cell stem cell 2019 cited by 97

  4. Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Owen N. Witte, David Baltimore, James S. Economou, Antoni Ribas - Clinical Cancer Research 2014 cited by 253

  5. Latency reversal plus natural killer cells diminish HIV reservoir in vivo

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 71

  6. A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells

    Authors: , , , , , , , , , , , , , , , - Cell stem cell 2016 cited by 382

  7. CD4 Ligation on Human Blood Monocytes Triggers Macrophage Differentiation and Enhances HIV Infection

    Authors: , , , , , - Journal of Virology 2014 cited by 101

  8. Negative Regulation of Neural Stem/Progenitor Cell Proliferation by the Pten Tumor Suppressor Gene in Vivo

    Authors: , , , , , , , , - Science 2001 cited by 795

  9. HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells

    Authors: , , , , , , , , , - Molecular Therapy 2015 cited by 148

  10. Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo

    Authors: , , , , , , , , , , , , , , - Cell Reports Medicine 2020 cited by 63

  11. Medial HOXA genes demarcate haematopoietic stem cell fate during human development

    Authors: , , , , , , , , , , , - Nature Cell Biology 2016 cited by 103

  12. Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic window

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 60

  13. Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susan M. Pond, David A. Cooper - Nature Medicine 2009 cited by 263

  14. Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS

    Authors: , , , , , , , , , , , , , , , , - PLoS Pathogens 2017 cited by 119

  15. HIV-1 Actively Replicates in Naive CD4+ T Cells Residing within Human Lymphoid Tissues

    Authors: , , , , , , , , , - Immunity 2001 cited by 231

  16. Expression-based monitoring of transcription factor activity: the TELiS database

    Authors: , , , , - Bioinformatics, Bioinform. 2004 cited by 190

  17. Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy

    Authors: , , , , , , , , - Nature Communications 2020 cited by 52

  18. International AIDS Society global scientific strategy: towards an HIV cure 2016

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cynthia Grossman, Gail E. Henderson, Timothy J. Henrich, Richard Jefferys, Hans-Peter Kiem, Joseph McCune, Keymanthri Moodley, Peter A. Newman, Monique Nijhuis, Moses Supercharger Nsubuga, Melanie Ott, Sarah Palmer, Douglas D. Richman, Asier Sáez‐Cirión, Matthew Sharp, Janet D. Siliciano, Guido Silvestri, Jerome Amir Singh, Bruno Spire, Jeffrey Taylor, Martin Tolstrup, Susana Valente, Jan van Lunzen, Rochelle P. Walensky, Ira Wilson, Jerome A. Zack - Nature Medicine 2016 cited by 422

  19. Female Human iPSCs Retain an Inactive X Chromosome

    Authors: , , , , , , , , , , , , , - Cell stem cell 2010 cited by 285

  20. HIV-1-Specific Chimeric Antigen Receptors Based on Broadly Neutralizing Antibodies

    Authors: , , , , , - Journal of Virology 2016 cited by 102

  21. CD4 on CD8 + T cells directly enhances effector function and is a target for HIV infection

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2004 cited by 83

  22. Stem cell–derived CAR T cells traffic to HIV reservoirs in macaques

    Authors: , , , , , , , , , - JCI Insight 2021 cited by 44

  23. Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 148

  24. Robust CAR-T memory formation and function via hematopoietic stem cell delivery

    Authors: , , , , , , , , , - PLoS Pathogens 2021 cited by 38